Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NYMALIZE ®safely and effectively. See full prescribing information for NYMALIZE. NYMALIZE (nimodipine) oral solution Initial U.S. Approval: 1988
Medication labelWhy this: Advisory · dailymed-prescription
NYMALIZE is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).
- generic_name
- nimodipine
- product_names
- nimodipine
- ndc
- 24338-260, 24338-260-10, 24338-260-12, 24338-260-08, 24338-230, 24338-230-05, 24338-230-12, 24338-230-15, 24338-230-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en